Guardant Health
GH
#1530
Rank
A$20.43 B
Marketcap
A$157.33
Share price
2.11%
Change (1 day)
176.85%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.85. In 2024 the company made an earnings per share (EPS) of A-$5.38 an increase over its 2023 EPS that were of A-$6.46.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.02-6.71%
2024A-$5.38-16.82%
2023A-$6.46-33.13%
2022A-$9.6760%
2021A-$6.0455.04%
2020A-$3.90207.14%
2019A-$1.27-19.81%
2018A-$1.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
A-$3.23-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A-$7.26 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA